Skyrizi identity
The active ingredient recorded for this profile is Risankizumab. Confirm the prescribed brand or ingredient before comparing packages.
Specialty Care medication reference
Skyrizi price reference.
Skyrizi (Risankizumab) has 9 European package references in this catalog. The listed range runs from 180 mg solution for injection · 1 unit at €4,051.24 to 150 mg solution for injection · 1 unit at €5,604.71. No source-supported U.S. cash comparison is published for this profile; the European references should be reviewed package by package. Figures are informational, not a quote or supply guarantee.
Estimated medicine cost range€4,051.24 – €5,604.71
Source-supported U.S. cash contextNot listed
Estimated price differenceCase-specific comparison
Last recorded source review
Reference profile
Clear information.
Case-specific review.
The listed range runs from 180 mg solution for injection · 1 unit at €4,051.24 to 150 mg solution for injection · 1 unit at €5,604.71. These figures are catalog references, not an offer to sell or a guarantee of supply. The correct product, package, destination, licensed provider and importer must be reviewed for each request.
Package-level price scope
The listed range runs from 180 mg solution for injection · 1 unit at €4,051.24 to 150 mg solution for injection · 1 unit at €5,604.71. Strength, dosage form and quantity can materially change a like-for-like comparison.
Comparison evidence
No source-supported U.S. cash comparison is published for this profile; the European references should be reviewed package by package.
Package references
Skyrizi listed formats
European figures are dated estimated medicine cost references. U.S. cash context appears only where the catalog retains source provenance; compare the exact strength, form and quantity.
9 of 9 package references shown
No package references match that search. Try a shorter strength, dosage form, supplier or PZN.
| Package reference | Estimated medicine cost reference | Comparable U.S. cash reference | Estimated difference | Source notes | Select |
|---|---|---|---|---|---|
| 180 mg solution for injection · 1 unit AbbVie Deutschland GmbH & Co. KG · PZN 19253838 | €4,051.24 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 360 mg solution for injection · 1 unit AbbVie Deutschland GmbH & Co. KG · PZN 18065017 | €4,051.24 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 600 mg solution for infusion · 1 unit AbbVie Deutschland GmbH & Co. KG · PZN 18065023 | €4,051.24 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 150 mg solution for injection in pre-filled pen · 1 pre-filled pen axicorp Pharma GmbH · PZN 17895716 | €5,450.03 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 75 mg solution for injection · 2 units Abacus Medicine A/S · PZN 15995000 | €5,450.44 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 150 mg solution for injection in pre-filled pen · 1 pre-filled pen Abacus Medicine A/S · PZN 17614717 | €5,451.09 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 150 mg solution for injection in pre-filled pen · 1 pre-filled pen CC Pharma GmbH · PZN 16835480 | €5,451.10 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 150 mg solution for injection in pre-filled pen · 1 pre-filled pen AbbVie Deutschland GmbH & Co. KG · PZN 16902070 | €5,604.71 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 150 mg solution for injection · 1 unit AbbVie Deutschland GmbH & Co. KG · PZN 16902087 | €5,604.71 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
Data scopeReference information, not a quote
Displayed amounts are dated catalog references and may not include every tax, dispensing, shipping or route-specific cost. Exact identity, availability, prescription, destination and import route require separate review. U.S. amounts are shown only for records with retained comparison provenance. US Med Access does not dispense or sell medicines and provides no medical advice. Review the pricing and data methodology before comparing packages.
How the references are preparedSources and editorial responsibility
Where this Skyrizi reference comes from
US Med Access publishes this page as an independent reference-information provider. Package records are retained with their available source notes and review dates; missing provenance is stated rather than inferred.
- Publisher and author
- US Med Access editorial team
- Recorded source review
- Reference scope
- 9 active European package records
01
European package source recordEuropean reference · medipreis.de
↗
02
European package source recordEuropean reference · medipreis.de
↗
03
European package source recordEuropean reference · medipreis.de
↗
04
European package source recordEuropean reference · medipreis.de
↗
05
US Med Access pricing and data methodologyMethodology · usmedaccess.com
↗
Frequently asked questions
Skyrizi price and package questions
Direct answers based on the package records shown on this page. They do not replace medical, regulatory or dispensing advice.
01What is the listed Skyrizi price in Europe?
The 9 listed European package references range from €4,051.24 – €5,604.71. The exact amount depends on strength, dosage form and pack quantity, so compare the specific package row rather than the range alone.
02Does this page include a U.S. cash-price comparison for Skyrizi?
No source-supported U.S. cash-price comparison is published for this profile. US Med Access does not estimate a U.S. figure when the catalog lacks adequate provenance.
03Are the listed Skyrizi amounts a quote or sale offer?
No. They are informational catalog references. US Med Access is an independent sourcing consultant and does not sell or dispense medicines. Current availability, route, prescription and total cost require separate review.
04How do I request the correct Skyrizi package?
Select the row that matches the prescribed strength, dosage form and quantity, then include the destination and request details. A package-level review is required before any next step.
Availability and logistics
Need a package-level review?
Start with the medication, package and destination. The sourcing team will assess the specific request without promising a supply, import or delivery outcome.